KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Tenet Healthcare (THC) over the last 13 years, with Q4 2025 value amounting to $224.0 million.

  • Tenet Healthcare's Receivables - Other rose 1789.47% to $224.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $224.0 million, marking a year-over-year increase of 1789.47%. This contributed to the annual value of $224.0 million for FY2025, which is 1789.47% up from last year.
  • According to the latest figures from Q4 2025, Tenet Healthcare's Receivables - Other is $224.0 million, which was up 1789.47% from $282.0 million recorded in Q3 2025.
  • Tenet Healthcare's 5-year Receivables - Other high stood at $315.0 million for Q1 2024, and its period low was $169.0 million during Q1 2022.
  • Over the past 5 years, Tenet Healthcare's median Receivables - Other value was $199.5 million (recorded in 2021), while the average stood at $217.2 million.
  • In the last 5 years, Tenet Healthcare's Receivables - Other soared by 6666.67% in 2024 and then crashed by 2539.68% in 2025.
  • Over the past 5 years, Tenet Healthcare's Receivables - Other (Quarter) stood at $199.0 million in 2021, then increased by 0.5% to $200.0 million in 2022, then increased by 4.0% to $208.0 million in 2023, then decreased by 8.65% to $190.0 million in 2024, then increased by 17.89% to $224.0 million in 2025.
  • Its last three reported values are $224.0 million in Q4 2025, $282.0 million for Q3 2025, and $264.0 million during Q2 2025.